HIV is infamous for its ability to hide in the human body for decades, typically requiring long-term treatment to prevent a ...

Merck's two-drug HIV regimen doravirine/islatravir maintained viral suppression and matched Gilead's Biktarvy in Phase 3 ...

More than 40 years after the first AIDS cases, new long-acting drugs and antibody-based therapies are reviving hopes that HIV ...

Merck (NYSE:MRK) reported positive results from late-stage studies on a new oral treatment which combines two drugs, ...

New guidance also spans prevention, screening, vaccines, mental health, and HIV-2, and is designed to help clinics manage older patients with complex needs.

The southern Africa nation recently met the UNAids 95-95-95 fast-track targets, meaning that 95% of those living with HIV ...

South Africa has welcomed a U.S. bridging plan worth $115 million to continue funding HIV treatment and prevention programs ...

Cuts proposed by the Trump administration and House Republicans could drive up new HIV cases by more than 200,000 by 2030, ...

Community advocates, health providers and local leaders in Charleston are all joining forces Wednesday in observance of ...

Activists from the same advocacy coalition — consisting of the groups Housing Works, Health GAP, and Disability Voters of ...

South Africa on Thursday welcomed a U.S. bridging plan worth $115 million that would continue funding HIV treatment and ...